Search
for
Sort by
Research 901–930 of 1000+
- The Development of BL 7660 as an Anti‐Acne Agent
- New allergens for the 21st century
- IRON DEFICIENCY: AN UNDER-RECOGNIZED PROBLEM IN KIDNEY TRANSPLANTATION. RISKS OF IRON TREATMENT.
- Characterization of Perifollicular Sheath Cell of Human Hair Follicle
- Orthopedic nursing practice guidelines. The NAON Standards Task Force.
- Spironolactone is an effective and well tolerated systemic anti-androgen therapy for hirsute women
- Spironolactone in the treatment of hirsutism.
- [PRACTICAL EXPERIENCES WITH OVULATION INHIBITION].
- Do Pleiotropic Effects of Spironolactone in Women with PCOS make it More Than an Anti-Androgen? Evidence from a Systematic Review and Meta-Analysis
- Effects of antiandrogen therapy of cyproteron acetate on androgen effects on the skin including androgenetic alopecia in menopausal women – case report: 10 years follow up –
- EVALUATION OF THE EFFECT OF TOPICALLY APPLIED METHYLSULFONYLMETHANE AND THEIR COMBINATION WITH MINOXIDIL SOLUTION FOR IMPROVEMENT OF HAIR GROWTH IN MALE MICE
- The Scalp
- Autologous Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: Results of a 54-Patient Prospective Study.
- Study the Physiological Effects of Finasteride (Prostacare) on some Reproductive Parameters in Male Rats (Rattus- Rattus)
- 174 Changes in urine androgen and PG levels during finasteride treatment
- [Finasteride inhibits microvascular density and VEGF expression in the seminal vesicle of rats].
- Finasteride
- PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY
- Influence of finasteride treatment on metabolic profile of men with androgenetic alopecia
- Semen Parameters Among Transgender Women With a History of Hormonal Treatment
- Interventions for chronic pruritus of unknown origin
- Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices
- A review of scalp camouflaging agents and prostheses for individuals with hair loss
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly l-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women